4 breakthrough therapies pharmacy departments should prepare for now

Four therapies have reshaped the outlook across oncology and metabolic disease in recent months. Two have already won FDA approval: a first-of-its-kind breast cancer drug guided by blood-based mutation detection and the first targeted pill for pancreatic cancer. A third, an mRNA melanoma vaccine, met its phase 3 primary endpoint and is moving toward regulatory […] The post 4 breakthrough therapies pharmacy departments should prepare for now appeared first on Becker's Hospital Review |...

Original Source

Read the full article at Beckershospitalreview →

KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.